Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Svenja Dieffenbacher"'
Autor:
Jan Philipp Radtke, Francesco Giganti, Manuel Wiesenfarth, Armando Stabile, Jose Marenco, Clement Orczyk, Veeru Kasivisvanathan, Joanne Nyaboe Nyarangi-Dix, Viktoria Schütz, Svenja Dieffenbacher, Magdalena Görtz, Albrecht Stenzinger, Wilfried Roth, Alex Freeman, Shonit Punwani, David Bonekamp, Heinz-Peter Schlemmer, Markus Hohenfellner, Mark Emberton, Caroline M Moore
Publikováno v:
PLoS ONE, Vol 14, Iss 8, p e0221350 (2019)
BackgroundRisk models (RM) need external validation to assess their value beyond the setting in which they were developed. We validated a RM combining mpMRI and clinical parameters for the probability of harboring significant prostate cancer (sPC, Gl
Externí odkaz:
https://doaj.org/article/4e1cafc4062a4c3aad8f30915356e089
Autor:
Viktoria Schuetz, Philipp Reimold, Magdalena Goertz, Luisa Hofer, Svenja Dieffenbacher, Joanne Nyarangi-Dix, Stefan Duensing, Markus Hohenfellner, Gencay Hatiboglu
Publikováno v:
Journal of Clinical Medicine, Vol 11, Iss 202, p 202 (2022)
Journal of Clinical Medicine
Journal of Clinical Medicine; Volume 11; Issue 1; Pages: 202
Journal of Clinical Medicine
Journal of Clinical Medicine; Volume 11; Issue 1; Pages: 202
Salvage radical prostatectomy (sRP) has evolved from open to minimally invasive approaches. sRP can be offered to patients with local recurrence to improve biochemical recurrence (BCR)-free and overall survival. We evaluate oncological outcome and co
Autor:
Katrin Kaltenecker, Viktoria Schuetz, Magdalena Goertz, Philipp Reimold, Svenja Dieffenbacher, Joanne Nyarangi-Dix, Markus Hohenfellner, David Wuerkner, Maximilian Guettlein, Georgi Tosev, Luisa Hofer
Publikováno v:
Journal of Urology. 206
INTRODUCTION AND OBJECTIVE:Since the introduction of rsRARP in 2010 three prospective RCTs comparing rsRARP and cRARP have been published. To further evaluate the results published until now we con...
Autor:
Lars Pursche, Elena Walter, Fabian Falkenbach, Ruth Himmelsbach, Martina Heller, Cathleen Nientiedt, Viktoria Schütz, Desiree Franke, Gita Schönberg, Christine Geisler, Jan Budczies, Svenja Dieffenbacher, Stefan Duensing, Philippa Lantwin, Iva Simunovic, Stefanie Zschäbitz, Stefan A. Koerber, Carine Pecqueux, Martina Kirchner, Christina Jurcic, Claudia Gasch, Jürgen Debus, Shirin Hoveida, Volker Endris, Gencay Hatiboglu, Rouven Behnisch, Markus Hohenfellner, Anette Duensing, Dirk Jäger, Joanne Nyarangi-Dix, Constantin Schwab, Peter Schirmacher, Holger Sültmann, Adam Kaczorowski, Magdalena Görtz, Mathias Rath, Albrecht Stenzinger, Philipp Reimold, Luisa Hofer
Publikováno v:
Urologic oncology. 40(1)
Background Mutations in DNA damage repair genes, in particular genes involved in homology-directed repair, define a subgroup of men with prostate cancer with a more unfavorable prognosis but a therapeutic vulnerability to PARP inhibition. In current
Autor:
Boris Hadaschik, Dogu Teber, I. V. Popeneciu, Svenja Dieffenbacher, Jan Philipp Radtke, Gencay Hatiboglu, Markus Hohenfellner
Publikováno v:
Urologia Internationalis. 99:162-167
Objective: To investigate the diagnostic accuracy of transperineal MRI/transrectal ultrasound (TRUS) fusion prostate biopsy vs. transrectal prostate biopsy in transurethral resection (TUR) specimen of men undergoing TUR of the prostate (TURP) for sym
Autor:
Markus Hohenfellner, Adam Kaczorowski, Viktoria Schütz, Desiree Franke, Stefan Duensing, Philippa Lantwin, Svenja Dieffenbacher, Weibin Hou, Maximilian Kippenberger
Publikováno v:
Pathobiology
Background/Objective: Clear cell renal cell carcinoma (ccRCC) is characterized by a high degree of functional intratumoral heterogeneity (ITH). This is highlighted by the finding that tumor cell proliferation and intracellular signaling occur prefere
Autor:
Philippa Lantwin, Frederik L. Giesel, Nassim Tawanaie Pour Sedehi, Dogu Teber, Anette Duensing, Magdalena Görtz, Elena Czink, Markus Hohenfellner, Rebecca Kreuter, Carine Pecqueux, Jonas Leichsenring, Peter Schirmacher, Martina Kirchner, Tobias Simpfendörfer, Anna-Lena Volckmar, Desiree Franke, Svenja Dieffenbacher, Joanne Nyarangi-Dix, Jürgen Debus, Jan-Philipp Radtke, Maximilian Jenzer, Volker Endris, Holger Sültmann, Leonidas Apostolidis, Shirin Hoveida, Cathleen Nientiedt, Clemens Kratochwil, Claudia Gasch, Katrin Kaltenecker, Viktoria Schütz, Stefan Duensing, Georgia Christofi, Olaf Neumann, Gencay Hatiboglu, Uwe Haberkorn, Carsten Grüllich, Stefan A. Koerber, Josef Mansour, Dirk Jäger, Georgi Tosev, Gita Schönberg, Albrecht Stenzinger, Luisa Hofer, Stefanie Zschäbitz, Sanjay Isaac
Publikováno v:
Urologic oncology. 38(7)
Background Defects in DNA damage repair genes characterize a subset of men with prostate cancer and provide an attractive opportunity for precision oncology approaches. The prevalence of such perturbations in newly diagnosed, treatment-naive patients
Autor:
Rowan Miller, Hiroshi Sasaki, Jelle O. Barentsz, Iztok Caglic, Jeries P. Zawaideh, Svenja Dieffenbacher, Nienke L. Hansen, Boris Hadaschik, Renu Eapen, Caroline M. Moore, Lukas Puellen, Dorota Czyzewska, Antonio C. Westphalen, Wayland Wang, Derek Sun, Muhammad Kahloon, Sonn Geoffrey, Spencer C. Behr, Tristan Barrett, Nancy Wang, Christof Kastner, Samir S. Taneja, Jeremy Grummet, Shengfei Oon
Publikováno v:
Journal of Urology. 201
Autor:
Viktoria Schütz, Marcus Hauffe, Claudia Kesch, Claudia Gasch, Heinz Peter Schlemmer, Maya B. Müller-Wolf, Caroline M. Moore, Francesco Giganti, Gencay Hatiboglu, Svenja Dieffenbacher, Stefan Duensing, Jan Philipp Radtke, Markus Hohenfellner, David Bonekamp, Joanne Nyarangi-Dix, Albrecht Stenzinger
Publikováno v:
European urology focus. 7(1)
Contemporary selection criteria for men with prostate cancer (PC) suitable for active surveillance (AS) are unsatisfactory, leading to high disqualification rates based on tumor misclassification. Conventional biopsy protocols are based on standard 1
Autor:
Michal R. Schweiger, Jürgen Debus, Mariska Luttje, Klaus H. Maier-Hein, Jan Philipp Radtke, Dogu Teber, Frederik L. Giesel, Claudia Kesch, Michael Götz, Manuel Wiesenfarth, Niels Grabe, Jörg Galle, Kathrin Wieczorek, Wilfried Roth, Axel Wintsche, Tobias Simpfendörfer, Carine Pecqueux, Heinz Peter Schlemmer, Holger Sültmann, Markus Hohenfellner, Svenja Dieffenbacher, Sven Perner, Sascha Pahernik, Dirk Jäger, Esther Herpel, Uwe Haberkorn, Carsten Grüllich, Martin T. Freitag, Stefan Duensing, Claudia Gasch, Boris Hadaschik, Gencay Hatiboglu, David Bonekamp, Gita Schönberg, Joanne Nyarangi-Dix, Antonia Dimitrakopoulou-Strauss, Anette Duensing
Publikováno v:
Scientific Reports
Scientific Reports, Vol 8, Iss 1, Pp 1-8 (2018)
Scientific Reports, Vol 8, Iss 1, Pp 1-8 (2018)
Magnetic resonance imaging (MRI) and prostate specific membrane antigen (PSMA)- positron emission tomography (PET)/computed tomography (CT)-imaging of prostate cancer (PCa) are emerging techniques to assess the presence of significant disease and tum